SAINBIOSE is major research center in translational and basic biomedical research endorsed by Inserm (U1059), the Jean Monnet University of Saint-Etienne and the Mines Saint-Etienne School of Engineering. It was founded in 2016, stemming from the pionner initiative of Saint-Etienne universities in the years 2000’s to bring together Engineering and Health Sciences together within a University Hospital campus (current campus santé where SAINBIOSE is located). SAINBIOSE gathers together 8 research groups (150 staff) organized in 2 teams: the DVH team working on hemostasis and vascular dysfunctions, and the LBTO team working on osteoarticular physiopathology and engineering. The common goal shared by all SAINBIOSE is to develop multiscale models (in silico and in vitro) for better understanding and adressing the interactions between inflammation and mechanobiology in cardiovascular and osteoarticular diseases. To achieve this, SAINBIOSE develops a scientific strategy based on a unique combination of scientific expertise spanning molecular and cellular biology, biomechanics and biomaterials, pharmacology and clinical translation. This approach generates both fundamental and translational advances applied to the global challenge of improving health and well-being for all." title="" class="btn" data-container="body" data-html="true" data-id="260106" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="SAnté INgéniérie BIOlogie St-Etienne (SAINBIOSE)"> 279
Activities
Entity types
Location
10 Rue de la Marandière, 42270 Saint-Priest-en-Jarez, France
Saint-Priest-en-Jarez
France
Employees
Scale: 51-200
Estimated: 13
Engaged catalyst
6Added in Motherbase
2 months, 4 weeks agoResearch lab: Health, Engineering and Biology
SAINBIOSE is major research center in translational and basic biomedical research endorsed by Inserm (U1059), the Jean Monnet University of Saint-Etienne and the Mines Saint-Etienne School of Engineering. It was founded in 2016, stemming from the pionner initiative of Saint-Etienne universities in the years 2000’s to bring together Engineering and Health Sciences together within a University Hospital campus (current campus santé where SAINBIOSE is located). SAINBIOSE gathers together 8 research groups (150 staff) organized in 2 teams: the DVH team working on hemostasis and vascular dysfunctions, and the LBTO team working on osteoarticular physiopathology and engineering. The common goal shared by all SAINBIOSE is to develop multiscale models (in silico and in vitro) for better understanding and adressing the interactions between inflammation and mechanobiology in cardiovascular and osteoarticular diseases. To achieve this, SAINBIOSE develops a scientific strategy based on a unique combination of scientific expertise spanning molecular and cellular biology, biomechanics and biomaterials, pharmacology and clinical translation. This approach generates both fundamental and translational advances applied to the global challenge of improving health and well-being for all.
medical research, bioengeneering, osteoarticular , vascular research, and health
Research lab: Health, Engineering and Biology
SAINBIOSE is major research center in translational and basic biomedical research endorsed by Inserm (U1059), the Jean Monnet University of Saint-Etienne and the Mines Saint-Etienne School of Engineering. It was founded in 2016, stemming from the pionner initiative of Saint-Etienne universities in the years 2000’s to bring together Engineering and Health Sciences together within a University Hospital campus (current campus santé where SAINBIOSE is located).
SAINBIOSE gathers together 8 research groups (150 staff) organized in 2 teams: the DVH team working on hemostasis and vascular dysfunctions, and the LBTO team working on osteoarticular physiopathology and engineering.
The common goal shared by all SAINBIOSE is to develop multiscale models (in silico and in vitro) for better understanding and adressing the interactions between inflammation and mechanobiology in cardiovascular and osteoarticular diseases. To achieve this, SAINBIOSE develops a scientific strategy based on a unique combination of scientific expertise spanning molecular and cellular biology, biomechanics and biomaterials, pharmacology and clinical translation. This approach generates both fundamental and translational advances applied to the global challenge of improving health and well-being for all.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Saint-Étienne Métropole Government Administration, French metropolis | Saint-Étienne Métropole Government Administration, French metropolis | Other 13 Jun 2025 | | |
![]() NASA - National Aeronautics and Space Administration Research, Aviation and Aerospace Component Manufacturing | NASA - National Aeronautics and Space Administration Research, Aviation and Aerospace Component Manufacturing | Other 19 May 2025 | | |
![]() GROUPE M6 Media, Broadcast Media Production and Distribution | GROUPE M6 Media, Broadcast Media Production and Distribution | Other 19 May 2025 | | |
![]() | Centre National d'Études Spatiales | Other 9 Apr 2025 | | |
![]() European Space Agency - ESA Defence and Aerospace, Aviation and Aerospace Component Manufacturing | European Space Agency - ESA Defence and Aerospace, Aviation and Aerospace Component Manufacturing | Other 9 Apr 2025 | | |
![]() | Carnot M.I.N.E.S | Other 21 Nov 2024 | |